To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MECP2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
413 supporting clones for gene MECP2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001110792.1   .a 1 to 1693 1 to 1693 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1693/1693
(100 %)
0 diff
(100 %id)
BX538060 human colon endothel primary cell culture .a 11 to 1693 1 to 1683   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1683/1683
(100 %)
3 diff
(99.9 %id)
BG706068 brain, hypothalamus .a 24 to 818 1 to 793       793/796
(99 %)
13 diff
(98.4 %id)
BI458175 brain, hypothalamus .a 24 to 854 1 to 828       828/830
(99 %)
17 diff
(98.0 %id)
CN288522 embryonic stem cells, DMSO-treated H9 cellline .a 35 to 573 1 to 541       541/541
(100 %)
3 diff
(99.5 %id)
BQ221374 large cell carcinoma, lung .a 48 to 832 12 to 809       798/908
(87 %)
27 diff
(97.1 %id)
BQ072357 pooled lung and spleen .a 49 to 1062 29 to 1051       1023/1059
(96 %)
37 diff
(96.6 %id)
CB138754 Liver .a 50 to 657 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
BG745572 Spleen .a 56 to 640 1 to 604       604/954
(63 %)
34 diff
(96.5 %id)
AY541280   .a 60 to 1563 1 to 1504   tiling clone,   1504/1504
(100 %)
0 diff
(100 %id)
BM263171 Islets of Langerhans, Pancreas .a 72 to 636 1 to 565       565/565
(100 %)
0 diff
(100 %id)
CN288526 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 76 to 605 1 to 530       530/530
(100 %)
0 diff
(100 %id)
DA890294 rectum .b 1 to 561 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
GQ203293   .b 17 to 10257 1 to 10242 S291V S292F I293Y R294P S295I ...     10242/10242
(100 %)
2 diff
(100.0 %id)
GQ203294   .b 17 to 10257 1 to 10241 F157L     10241/10241
(100 %)
2 diff
(100.0 %id)
GQ203295   .b 17 to 10257 1 to 10243 S486I     10243/10243
(100 %)
2 diff
(100.0 %id)
GQ896382   .b 17 to 10257 1 to 10241 P430S     10241/10241
(100 %)
2 diff
(100.0 %id)
GU479943   .b 17 to 10257 1 to 10241 exact     10241/10241
(100 %)
2 diff
(100.0 %id)
HM020402   .b 17 to 10257 1 to 10237 K286P A287*     10237/10237
(100 %)
5 diff
(100.0 %id)
HM156732   .b 17 to 10257 1 to 10241 G103D     10241/10241
(100 %)
2 diff
(100.0 %id)
HM156733   .b 17 to 10257 1 to 10242 exact     10242/10242
(100 %)
2 diff
(100.0 %id)
NM_004992.3   .b 17 to 10257 1 to 10241 exact RefSeq,   10241/10241
(100 %)
1 diff
(100.0 %id)
DA969957 stomach .b 32 to 609 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BP363723 lung .b 32 to 614 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BI222539 cervical carcinoma cell line, cervix .b 33 to 838 1 to 801       801/803
(99 %)
15 diff
(98.2 %id)
AK289444 bladder .b 42 to 1833 1 to 1792 A201V A257T     1792/1792
(100 %)
2 diff
(99.9 %id)
DA042231 bladder .b 43 to 609 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BP198942 brain .b 46 to 629 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
CR612728 neuroblastoma .b 46 to 1125 1 to 1080       1080/1080
(100 %)
0 diff
(100 %id)
AL703584 human skeletal muscle .b 49 to 437 1 to 389       389/389
(100 %)
1 diff
(99.8 %id)
BX404450 neuroblastoma .b 57 to 872 10 to 825       816/825
(98 %)
38 diff
(95.4 %id)
BX404543 neuroblastoma .b 57 to 1078 10 to 1022       1013/1056
(95 %)
25 diff
(97.7 %id)
BF348074 anaplastic oligodendroglioma with 1p/19qloss, brain .b 57 to 820 1 to 761       759/800
(94 %)
23 diff
(97.2 %id)
BQ049377 lymph, lymphoma, cell line .b 63 to 920 1 to 869       869/869
(100 %)
16 diff
(98.2 %id)
BI857780 breast, mammary adenocarcinoma, cell line .b 64 to 838 1 to 772       772/772
(100 %)
7 diff
(99.1 %id)
TI_57191044   .b 64 to 838 60 to 831       772/772
(100 %)
7 diff
(99.1 %id)
BG422554 Kidney, renal cell adenocarcinoma .b 66 to 864 1 to 793       793/852
(93 %)
15 diff
(98.3 %id)
BI821242 pooled brain, lung, testis .b 71 to 886 1 to 817       817/818
(99 %)
6 diff
(99.3 %id)
TI_57197918   .b 71 to 886 29 to 845       817/846
(96 %)
12 diff
(98.6 %id)
AF158180   .b 76 to 10257 1 to 10182 exact tiling clone,   10182/10182
(100 %)
1 diff
(100.0 %id)
BI517610 pooled colon, kidney, stomach .b 77 to 842 1 to 772       772/772
(100 %)
24 diff
(96.9 %id)
TI_45236465   .b 77 to 842 61 to 832       772/832
(92 %)
29 diff
(96.6 %id)
BI223414 cervical carcinoma cell line, cervix .b 78 to 767 1 to 693       693/693
(100 %)
12 diff
(98.3 %id)
CN288520 embryonic stem cells, cell lines H1, H7, andH9 .b 92 to 619 1 to 527       527/535
(98 %)
2 diff
(99.7 %id)
BX430982 brain, fetal brain .b 145 to 936 1 to 780       780/860
(90 %)
59 diff
(93.2 %id)
BX430983 brain, fetal brain .b 145 to 1023 1 to 856       856/856
(100 %)
26 diff
(97.0 %id)
BC011612 Placenta, choriocarcinoma .b 159 to 1833 1 to 1675 exact available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1675/1675
(100 %)
0 diff
(100 %id)
BE903173 choriocarcinoma, placenta .b 159 to 981 26 to 842       817/909
(89 %)
14 diff
(98.5 %id)
L37298   .b 162 to 1830 1 to 1669 exact     1669/1669
(100 %)
6 diff
(99.7 %id)
AJ132917   .b 168 to 10258 1 to 10091 exact     10091/10091
(100 %)
5 diff
(100.0 %id)
X99686   .b 169 to 1701 1 to 1533       1533/1533
(100 %)
2 diff
(99.9 %id)
BG773865 choriocarcinoma, placenta .b 171 to 879 1 to 708       708/709
(99 %)
5 diff
(99.3 %id)
AA594867 normal prostate, Prostate .b 172 to 344 173 to 1       173/173
(100 %)
0 diff
(100 %id)
Y12643 placenta .b 179 to 1830 1 to 1652 exact     1652/1652
(100 %)
2 diff
(99.9 %id)
R18712 whole brain .b 235 to 590 1 to 359       359/539
(66 %)
6 diff
(98.9 %id)
CV027834 mixed .b 243 to 860 1 to 618       618/618
(100 %)
0 diff
(100 %id)
GU812285   .b 243 to 1703 1 to 1462 R162K G163R S164E S166L R167P ...     1462/1462
(100 %)
1 diff
(100.0 %id)
GU812286   .b 243 to 1703 1 to 1461 H51Q     1461/1461
(100 %)
1 diff
(100.0 %id)
TI_1948080494   .b 265 to 1036 145 to 914   fully sequenced,   770/914
(84 %)
8 diff
(99.2 %id)
TI_1948080669   .b 265 to 1045 152 to 921   fully sequenced,   770/921
(83 %)
7 diff
(99.3 %id)
TI_1948080848   .b 265 to 1075 148 to 950   fully sequenced,   803/950
(84 %)
9 diff
(99.1 %id)
CR598471 Neuroblastoma Cot 25-normalized .b 266 to 1801 1 to 1536       1536/1536
(100 %)
0 diff
(100 %id)
BX394404 Neuroblastoma Cot 25-normalized .b 266 to 1006 1 to 728   fully sequenced,   728/728
(100 %)
2 diff
(99.8 %id)
CR604541 Neuroblastoma Cot 25-normalized .b 269 to 1792 1 to 1524       1524/1524
(100 %)
0 diff
(100 %id)
BX457821 neuroblastoma .b 269 to 1095 1 to 829       827/829
(99 %)
10 diff
(98.8 %id)
BX324534 Neuroblastoma Cot 25-normalized .b 269 to 941 1 to 671   fully sequenced,   671/671
(100 %)
1 diff
(99.9 %id)
BE797838 lung, small cell carcinoma .b 269 to 1000 89 to 808       720/1028
(70 %)
24 diff
(97.7 %id)
CF146278 CNCAP(3)T-225 cell line, Prostate .b 269 to 878 1 to 605       605/605
(100 %)
9 diff
(98.6 %id)
CF146480 CNCAP(3)T-225 cell line, Prostate .b 269 to 987 1 to 717       717/717
(100 %)
9 diff
(98.8 %id)
X89430 skeletal muscle .b 269 to 2616 1 to 2346       2346/2351
(99 %)
9 diff
(99.7 %id)
TI_154178689   .b 277 to 1095 69 to 873       805/840
(95 %)
24 diff
(97.2 %id)
TI_154178937   .b 277 to 1095 69 to 875       807/907
(88 %)
19 diff
(98.0 %id)
BQ329531 lung_normal .b 304 to 794 1 to 497       497/497
(100 %)
37 diff
(92.6 %id)
AA643745 colon, colon tumor RER+ .b 330 to 814 521 to 38       484/521
(92 %)
9 diff
(98.3 %id)
BE747607 adenocarcinoma cell line, ovary .b 362 to 996 1 to 645       645/645
(100 %)
27 diff
(95.9 %id)
CT003057 T-Lymphocytes .b 369 to 1100 1 to 732       732/744
(98 %)
4 diff
(99.5 %id)
BQ883514 melanotic melanoma, cell line, skin .b 546 to 1364 1 to 829       829/926
(89 %)
21 diff
(97.8 %id)
BQ878956 melanotic melanoma, cell line, skin .b 547 to 1438 1 to 898       898/906
(99 %)
8 diff
(99.2 %id)
BQ681323 melanotic melanoma, cell line, skin .b 547 to 1458 1 to 918       918/919
(99 %)
13 diff
(98.6 %id)
AA279367.
matches multiple genes
germinal center B cell .b 549 to 945 1 to 396     also hits gene GLS 396/397
(99 %)
4 diff
(99.0 %id)
BX281740 Bone, osteosarcoma, cell line .b 601 to 1089 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BG113255 Bone, osteosarcoma, cell line .b 601 to 1286 1 to 685       685/960
(71 %)
11 diff
(98.9 %id)
CN288523 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 633 to 1347 1 to 715       715/715
(100 %)
0 diff
(100 %id)
AW752463 colon .b 669 to 915 13 to 258       246/258
(95 %)
6 diff
(97.7 %id)
AW752453 colon .b 675 to 915 1 to 239       239/239
(100 %)
3 diff
(98.8 %id)
AW752458 colon .b 675 to 915 1 to 239       239/239
(100 %)
3 diff
(98.8 %id)
BU527569 epidermoid carcinoma, cell line, lung .b 698 to 1301 1 to 619       619/881
(70 %)
22 diff
(97.6 %id)
BF983265 duodenal adenocarcinoma, cell line, small intestine .b 733 to 1383 1 to 647       647/665
(97 %)
11 diff
(98.4 %id)
BX404542 neuroblastoma .b 800 to 1798 993 to 1       993/1047
(94 %)
1 diff
(100.0 %id)
CR998028 T-Lymphocytes .b 836 to 1451 1 to 617       617/621
(99 %)
3 diff
(99.6 %id)
BE612798 adenocarcinoma, ovary .b 848 to 1369 1 to 521       521/529
(98 %)
1 diff
(99.9 %id)
AA371980 pituitary gland .b 851 to 1127 1 to 278       278/278
(100 %)
1 diff
(99.7 %id)
BE899573 adenocarcinoma cell line, ovary .b 905 to 1400 35 to 524       490/1070
(45 %)
13 diff
(98.8 %id)
BX324533 Neuroblastoma Cot 25-normalized .b 911 to 1792 874 to 1   fully sequenced,   874/874
(100 %)
13 diff
(98.6 %id)
BM790174 stomach .b 916 to 1497 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM850695 stomach .b 916 to 1453 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BF900075 marrow .b 931 to 1233 1 to 303       303/303
(100 %)
3 diff
(99.1 %id)
BQ721642 sympathetic trunk .b 944 to 1766 1 to 831       831/915
(90 %)
34 diff
(96.3 %id)
BU190991 ductal carcinoma, cell line, Pancreas .b 951 to 1825 1 to 880       880/959
(91 %)
27 diff
(97.2 %id)
BX394403 Neuroblastoma Cot 25-normalized .b 976 to 1801 812 to 1   fully sequenced,   812/812
(100 %)
3 diff
(99.7 %id)
TI_227714093   .b 992 to 1833 924 to 90   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 835/941
(88 %)
9 diff
(99.1 %id)
TI_1948080495   .b 1006 to 1708 834 to 123   fully sequenced,   712/834
(85 %)
6 diff
(99.3 %id)
TI_1948080670   .b 1015 to 1707 815 to 124   fully sequenced,   692/815
(84 %)
5 diff
(99.4 %id)
TI_1948080849   .b 1045 to 1708 778 to 123   fully sequenced,   656/778
(84 %)
5 diff
(99.4 %id)
BG163877 hypernephroma, cell line, Kidney .b 1049 to 1393 1 to 345       345/387
(89 %)
1 diff
(99.8 %id)
CB528669 Aveolar Macrophage, lung .b 1128 to 1830 721 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 703/703
(100 %)
0 diff
(100 %id)
CD364821 Alveolar Macrophage, lung .b 1128 to 1833 724 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 706/706
(100 %)
0 diff
(100 %id)
AI580111 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1134 to 1836 703 to 4       700/706
(99 %)
0 diff
(100 %id)
BP431331   .b 1142 to 1473 1 to 332       332/332
(100 %)
4 diff
(98.8 %id)
BM707282 eye, eye anterior segment .b 1168 to 1643 9 to 484       476/484
(98 %)
9 diff
(98.2 %id)
BU632119 cell lines, Chondrosarcoma .b 1172 to 1833 680 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 662/662
(100 %)
3 diff
(99.6 %id)
CA425003 cell lines, Chondrosarcoma .b 1172 to 1830 678 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 660/660
(100 %)
2 diff
(99.7 %id)
C02973 heart .b 1218 to 1449 1 to 239       239/244
(97 %)
11 diff
(95.5 %id)
BM998042 lung, Metastatic Chondrosarcoma .b 1228 to 1833 625 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 607/607
(100 %)
1 diff
(99.9 %id)
BE046395 colon, juvenile granulosa tumor .b 1236 to 1831 599 to 2       598/601
(99 %)
0 diff
(100 %id)
BQ027224 lung, Metastatic Chondrosarcoma .b 1243 to 1833 609 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 591/591
(100 %)
0 diff
(100 %id)
BM711592 eye, human retina .b 1255 to 1712 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
BQ001073 lung, Metastatic Chondrosarcoma .b 1284 to 1833 568 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 550/554
(99 %)
1 diff
(99.9 %id)
AI207011 pooled germ cell tumors .b 1345 to 1835 488 to 1       488/492
(99 %)
5 diff
(99.0 %id)
TI_151704554   .b 1345 to 1830 574 to 88   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 487/973
(50 %)
35 diff
(96.5 %id)
BU633326 cell lines, Chondrosarcoma .b 1356 to 1836 496 to 16       481/496
(96 %)
0 diff
(100 %id)
CA435968 lung, Metastatic Chondrosarcoma .b 1360 to 1833 494 to 21       474/494
(95 %)
0 diff
(100 %id)
AI636877 pooled germ cell tumors .b 1367 to 1835 468 to 1       468/468
(100 %)
4 diff
(99.2 %id)
AI753361 bone marrow stroma .b 1370 to 1833 482 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 464/464
(100 %)
1 diff
(99.8 %id)
AA253289 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1384 to 1724 1 to 337       337/337
(100 %)
10 diff
(97.1 %id)
TI_151742137   .b 1395 to 1836 556 to 115       442/556
(79 %)
0 diff
(100 %id)
AI590746 brain, tumor, 5 pooled (see description) .b 1402 to 1833 459 to 29   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 431/442
(97 %)
11 diff
(97.6 %id)
F20898 pectoral muscle (after mastectomy) .b 1426 to 1805 1 to 381       381/381
(100 %)
4 diff
(99.0 %id)
AA279313 germinal center B cell .b 1453 to 1833 411 to 34   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 378/386
(97 %)
22 diff
(94.4 %id)
AA970365 pooled .b 1491 to 1698 208 to 1       208/208
(100 %)
5 diff
(97.6 %id)
EC533207 Prostate .b 1498 to 1592 93 to 1       93/97
(95 %)
4 diff
(95.9 %id)
DW419411 Liver .b 1514 to 1799 17 to 303       287/303
(94 %)
6 diff
(98.1 %id)
CA433671 mixed .b 1528 to 1830 321 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 303/303
(100 %)
4 diff
(98.7 %id)
AA543089 colon .b 1604 to 1836 236 to 4       233/236
(98 %)
0 diff
(100 %id)
AW501805 lymph .b 2213 to 2618 1 to 406       406/406
(100 %)
3 diff
(99.3 %id)
CF143537 lymph .b 2213 to 2593 1 to 381       381/381
(100 %)
4 diff
(99.0 %id)
CF143254 lymph .b 2213 to 2612 1 to 400       400/400
(100 %)
6 diff
(98.5 %id)
TI_154156993   .b 2219 to 2722 93 to 596       504/506
(99 %)
6 diff
(98.9 %id)
TI_154174585   .b 2219 to 2688 80 to 555       476/845
(56 %)
13 diff
(98.5 %id)
TI_154174979   .b 2219 to 2613 77 to 471       395/395
(100 %)
1 diff
(99.8 %id)
AW276994 ovary, papillary serous ovarian metastasis .b 2714 to 3023 40 to 349     Submitted on the opposite strand 310/357
(86 %)
3 diff
(99.2 %id)
AW276885 ovary, papillary serous ovarian metastasis .b 2714 to 3023 9 to 318     Submitted on the opposite strand 310/326
(95 %)
3 diff
(99.1 %id)
CD619580   .b 2981 to 3609 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
CN288516 embryonic stem cells, cell lines H1, H7, andH9 .b 3017 to 3604 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
CD619579   .b 3085 to 3864 775 to 1       775/775
(100 %)
7 diff
(99.1 %id)
AL157555 amygdala .b 3130 to 4004 1 to 873       873/874
(99 %)
3 diff
(99.7 %id)
BF948800 nervous_normal .b 3354 to 3605 282 to 30       253/298
(84 %)
0 diff
(100 %id)
BQ067901 brain .b 3509 to 4440 4 to 945       942/1049
(89 %)
29 diff
(97.3 %id)
BQ067965 brain .b 3526 to 4422 1 to 901       901/1037
(86 %)
15 diff
(98.6 %id)
CK000625 mixed .b 3869 to 4591 17 to 735       719/751
(95 %)
3 diff
(99.7 %id)
BI255814 cervical carcinoma cell line, cervix .b 3972 to 4506 1 to 539       539/541
(99 %)
8 diff
(98.6 %id)
M62144   .b 3998 to 4261 7 to 270       264/270
(97 %)
5 diff
(98.2 %id)
BU429338 lymph .b 4052 to 4489 8 to 445       438/445
(98 %)
6 diff
(98.7 %id)
TI_154150360   .b 4052 to 4575 77 to 608       532/878
(60 %)
14 diff
(98.5 %id)
AA584893 pheochromocytoma .b 4066 to 4512 1 to 447     Submitted on the opposite strand 447/447
(100 %)
1 diff
(99.8 %id)
CD558172 White Matter .b 4140 to 4950 1 to 821       821/889
(92 %)
24 diff
(97.4 %id)
BE778235 eye, retinoblastoma .b 4364 to 5153 1 to 782       782/905
(86 %)
30 diff
(96.7 %id)
BX509998   .b 4470 to 5038 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BE872494 adenocarcinoma, colon .b 4564 to 5209 1 to 638       638/903
(70 %)
21 diff
(97.7 %id)
DA207978 brain .b 4631 to 5197 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA197616 brain .b 4652 to 5171 2 to 522   capped   521/521
(100 %)
1 diff
(99.9 %id)
CD244418 testis .b 4661 to 5225 1 to 571       571/1042
(54 %)
14 diff
(98.7 %id)
BC031833 Prostate, adenocarcinoma. .b 4684 to 7313 1 to 2630   available from MGC, AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 2630/2630
(100 %)
1 diff
(100.0 %id)
DA788642 brain .b 4717 to 5001 2 to 286   capped   285/285
(100 %)
0 diff
(100 %id)
DA943855 Spleen .b 4720 to 5285 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CN288524 embryonic stem cells, cell lines H1, H7, andH9 .b 4758 to 5409 1 to 653       653/653
(100 %)
4 diff
(99.4 %id)
BU845058 ovary, teratocarcinoma, cell line .b 4785 to 5679 1 to 903       903/914
(98 %)
10 diff
(99.0 %id)
BG420656 Kidney, renal cell adenocarcinoma .b 4787 to 5467 1 to 678       678/678
(100 %)
13 diff
(98.1 %id)
BQ216211 embryonal carcinoma, cell line, testis .b 4982 to 5869 1 to 889       889/890
(99 %)
11 diff
(98.8 %id)
DB127119 thymus .b 4987 to 5493 2 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
DB178148 kidney, tumor tissue .b 5034 to 5480 2 to 449   capped   448/448
(100 %)
2 diff
(99.6 %id)
BP344062 synovial membrane .b 5054 to 5636 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
CN288521 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 5059 to 5594 1 to 536       536/536
(100 %)
5 diff
(99.1 %id)
DA496465 brain .b 5117 to 5708 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
AW176162 breast .b 5146 to 5477 1 to 332       332/332
(100 %)
4 diff
(98.8 %id)
AW176194 breast .b 5146 to 5477 1 to 332       332/332
(100 %)
4 diff
(98.8 %id)
BP293771 lung .b 5146 to 5724 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
BP293962 lung .b 5146 to 5725 1 to 583       583/583
(100 %)
10 diff
(98.3 %id)
BE795847 lung, small cell carcinoma .b 5158 to 5780 1 to 643       643/643
(100 %)
23 diff
(96.5 %id)
BM465147 eye, retinoblastoma .b 5201 to 5909 1 to 725       725/1049
(69 %)
19 diff
(98.2 %id)
EC462901 Prostate .b 5209 to 5296 1 to 88       88/88
(100 %)
3 diff
(96.6 %id)
EC565663 Prostate .b 5216 to 5296 12 to 91       80/91
(87 %)
6 diff
(93.5 %id)
BF794419 lymph, lymphoma, cell line .b 5429 to 6164 1 to 733       733/981
(74 %)
15 diff
(98.5 %id)
BE693824 breast .b 5612 to 5919 1 to 310       310/325
(95 %)
5 diff
(98.5 %id)
CN288517 embryonic stem cells, DMSO-treated H9 cellline .b 5641 to 6124 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
BE277565 melanotic melanoma, skin .b 5735 to 6362 19 to 646       628/646
(97 %)
6 diff
(99.1 %id)
BE386813 melanotic melanoma, skin .b 5736 to 6296 20 to 581       562/581
(96 %)
6 diff
(99.0 %id)
BG281756 melanotic melanoma, skin .b 5764 to 6415 1 to 653       653/654
(99 %)
5 diff
(99.3 %id)
BG477731 melanotic melanoma, skin .b 5764 to 6576 1 to 817       817/1054
(77 %)
21 diff
(98.1 %id)
BE276504 melanotic melanoma, skin .b 5784 to 6381 1 to 595       595/595
(100 %)
4 diff
(99.4 %id)
BE276461 melanotic melanoma, skin .b 5784 to 6479 1 to 691       691/715
(96 %)
15 diff
(98.0 %id)
BM925987 brain .b 5852 to 6726 7 to 896       890/1135
(78 %)
30 diff
(97.4 %id)
AW577477 breast .b 5872 to 6236 90 to 454       365/469
(77 %)
1 diff
(99.8 %id)
BG036546 adenocarcinoma, cell line, Prostate .b 5903 to 6681 1 to 770       770/986
(78 %)
70 diff
(93.0 %id)
F06993 brain, total brain .b 6019 to 6326 1 to 308       308/308
(100 %)
2 diff
(99.4 %id)
CN288518 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 6042 to 6659 5 to 622       618/622
(99 %)
5 diff
(99.2 %id)
AI885922 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 6105 to 6289 247 to 63   AAA   185/236
(78 %)
0 diff
(100 %id)
EB387998 eye, optic nerve .b 6108 to 6929 1 to 822       822/822
(100 %)
0 diff
(100 %id)
H82599 melanocyte .b 6141 to 6533 1 to 411       411/416
(98 %)
15 diff
(96.4 %id)
AA490384 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 6142 to 6500 1 to 359       359/359
(100 %)
1 diff
(99.8 %id)
BE327648 carcinoid, lung .b 6151 to 6488 1 to 338     Submitted on the opposite strand 338/338
(100 %)
2 diff
(99.5 %id)
BG741923 skin .b 6242 to 7091 1 to 853       853/853
(100 %)
8 diff
(99.1 %id)
BF968140 adrenal cortex carcinoma, cell line, adrenal gland .b 6324 to 7085 1 to 764       764/839
(91 %)
25 diff
(97.1 %id)
BP207158 coronary artery .b 6371 to 6934 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BI913069 brain .b 6380 to 7263 1 to 874       874/878
(99 %)
21 diff
(97.7 %id)
TI_57240961   .b 6380 to 7263 34 to 907       874/911
(95 %)
21 diff
(97.7 %id)
T65711 lung .b 6385 to 6751 1 to 377       377/378
(99 %)
11 diff
(97.1 %id)
BU902034 leiomyosarcoma, uterus .b 6427 to 7313 1 to 887   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 887/887
(100 %)
0 diff
(100 %id)
EC533479 Prostate .b 6479 to 6576 1 to 98       98/102
(96 %)
1 diff
(99.1 %id)
EC445737 Prostate .b 6480 to 6576 1 to 97       97/101
(96 %)
1 diff
(99.1 %id)
EC474942 Prostate .b 6480 to 6576 1 to 96       96/100
(96 %)
2 diff
(98.0 %id)
EC489686 Prostate .b 6480 to 6576 1 to 97       97/101
(96 %)
1 diff
(99.1 %id)
BG960328 colon .b 6550 to 6952 1 to 399       399/399
(100 %)
16 diff
(96.0 %id)
DA340091 hippocampus .b 6615 to 7218 2 to 605   capped   604/604
(100 %)
1 diff
(99.9 %id)
BP420001 small intestine .b 6623 to 7122 1 to 500     Submitted on the opposite strand 500/502
(99 %)
1 diff
(99.9 %id)
BQ326730 colon_normal .b 6658 to 7022 379 to 1       379/380
(99 %)
25 diff
(93.5 %id)
BF061649 fibrotheoma, ovary .b 6673 to 7165 496 to 4       493/496
(99 %)
0 diff
(100 %id)
BE781565 eye, retinoblastoma .b 6702 to 7320 1 to 621       621/650
(95 %)
8 diff
(98.8 %id)
BI017927 lung_tumor .b 6704 to 7019 317 to 1       317/317
(100 %)
11 diff
(96.6 %id)
CB044881 colon, juvenile granulosa tumor .b 6768 to 7240 491 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 475/475
(100 %)
5 diff
(99.0 %id)
T64441 lung .b 6803 to 7240 443 to 1       443/443
(100 %)
12 diff
(97.3 %id)
AI631140 pooled germ cell tumors .b 6820 to 7318 498 to 1       498/498
(100 %)
1 diff
(99.8 %id)
DW426913 Liver .b 6824 to 7087 17 to 280       264/280
(94 %)
11 diff
(96.1 %id)
AI827462 pooled .b 6830 to 7318 489 to 1       489/489
(100 %)
4 diff
(99.2 %id)
AI077449 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 6875 to 7314 440 to 1       440/440
(100 %)
3 diff
(99.4 %id)
AI955326 brain, four pooled pituitary adenomas .b 6886 to 7335 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI339615 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 6893 to 7351 463 to 5       459/463
(99 %)
0 diff
(100 %id)
CA396642 eye, RPE/choroid .b 6897 to 7559 1 to 663       663/663
(100 %)
0 diff
(100 %id)
DA123008 cerebellum .b 6901 to 7463 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
AI278296 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 6910 to 7351 446 to 5       442/446
(99 %)
0 diff
(100 %id)
AI224490 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 6919 to 7326 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI439398 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 6929 to 7318 390 to 1       390/390
(100 %)
0 diff
(100 %id)
AI866995 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 6932 to 7319 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AW613981 pooled germ cell tumors .b 6939 to 7318 381 to 1       381/381
(100 %)
3 diff
(99.3 %id)
AW025137 Kidney .b 6988 to 7318 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AI003203 schizophrenic brain S-11 frontal lobe .b 7008 to 7326 319 to 1       319/319
(100 %)
0 diff
(100 %id)
AA557230 breast .b 7027 to 7321 295 to 1       295/295
(100 %)
0 diff
(100 %id)
AW262966 adenocarcinoma, Pancreas .b 7028 to 7333 306 to 1       306/306
(100 %)
4 diff
(98.7 %id)
Z41666 brain, total brain .b 7033 to 7313 281 to 1       281/281
(100 %)
0 diff
(100 %id)
AA832448 germinal center B cell .b 7040 to 7325 288 to 3       286/288
(99 %)
0 diff
(100 %id)
AI572512 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 7052 to 7351 304 to 5       300/304
(98 %)
0 diff
(100 %id)
AI381864 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 7052 to 7318 274 to 8       267/274
(97 %)
0 diff
(100 %id)
DA792707 brain .b 7064 to 7691 2 to 631   capped   630/631
(99 %)
3 diff
(99.6 %id)
AI611806 brain, tumor, 5 pooled (see description) .b 7075 to 7325 254 to 4       251/254
(98 %)
0 diff
(100 %id)
AA843519 parathyroid gland, parathyroid tumor .b 7094 to 7546 17 to 465     Submitted on the opposite strand 449/465
(96 %)
6 diff
(98.8 %id)
AW295684   .b 7094 to 7334 240 to 2       239/279
(85 %)
0 diff
(100 %id)
BM456136 lymph, lymphoma, cell line .b 7094 to 7735 33 to 674       642/900
(71 %)
17 diff
(98.2 %id)
DA660916   .b 7129 to 7674 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
CN288525 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 7142 to 7883 1 to 742       742/742
(100 %)
1 diff
(99.9 %id)
DA463357   .b 7178 to 7729 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA958075 Spleen .b 7190 to 7732 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
R09924 liver and spleen .b 7199 to 7322 1 to 124       124/124
(100 %)
0 diff
(100 %id)
DB137464 thymus .b 7276 to 7822 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
TI_149278616   .b 7287 to 7989 791 to 89   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 703/704
(99 %)
2 diff
(99.8 %id)
BU678549 lung, Primary Lung Epithelial Cells .b 7321 to 7989 687 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 669/669
(100 %)
0 diff
(100 %id)
BQ877133 epidermoid carcinoma, cell line, lung .b 7376 to 7866 1 to 490       490/970
(50 %)
6 diff
(99.4 %id)
AW407215 lymph .b 7408 to 7843 1 to 436       436/436
(100 %)
5 diff
(98.9 %id)
DA768716 brain .b 7408 to 7932 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
TI_154145134   .b 7414 to 8038 80 to 708       629/631
(99 %)
36 diff
(94.3 %id)
DA122159 cerebellum .b 7487 to 8045 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AA322856 brain, cerebellum .b 7491 to 7697 1 to 207       207/207
(100 %)
0 diff
(100 %id)
AL702939 human skeletal muscle .b 7550 to 8300 1 to 751       751/751
(100 %)
2 diff
(99.8 %id)
CN288515 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 7664 to 8189 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
DA439912 tongue, tumor tissue .b 7701 to 8275 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA440541 tongue, tumor tissue .b 7701 to 8247 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
R12573 liver and spleen .b 7716 to 7973 266 to 1       266/266
(100 %)
10 diff
(96.3 %id)
BF344073 brain, glioblastoma with EGFR amplification .b 7730 to 8409 1 to 680       680/1470
(46 %)
35 diff
(97.7 %id)
DB252608 uterus .b 7808 to 8358 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA383857 thalamus .b 7810 to 8453 2 to 645   capped   644/644
(100 %)
2 diff
(99.7 %id)
DA687593   .b 7818 to 8359 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA790745 brain .b 7838 to 8367 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BM967227 Islets of Langerhans, Pancreas .b 7887 to 8461 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BQ129289 Islets of Langerhans, Pancreas .b 7887 to 8366 1 to 480       480/480
(100 %)
0 diff
(100 %id)
DA067198 cerebellum .b 7913 to 8476 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BE244753 leukopheresis .b 7936 to 8311 1 to 376       376/376
(100 %)
0 diff
(100 %id)
DA259590 caudate nucleus .b 7944 to 8500 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CA390138 eye, RPE/choroid .b 7944 to 8489 1 to 546       546/546
(100 %)
0 diff
(100 %id)
DA077884 cerebellum .b 7954 to 8534 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
R85012 brain .b 7965 to 8277 1 to 313       313/315
(99 %)
3 diff
(99.1 %id)
AA284224 germinal center B cell .b 7966 to 8359 1 to 393       393/393
(100 %)
1 diff
(99.8 %id)
AA888593 carcinoid, lung .b 7977 to 8451 1 to 475     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
DA160695 amygdala .b 7978 to 8485 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
DA059912 cerebellum .b 8007 to 8508 2 to 504   capped   503/503
(100 %)
2 diff
(99.7 %id)
BP292640 lung .b 8009 to 8587 1 to 579       579/580
(99 %)
1 diff
(99.9 %id)
BM715775 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 8062 to 8771 1 to 708       708/708
(100 %)
2 diff
(99.8 %id)
TI_151777317   .b 8065 to 8571 108 to 619       512/1358
(37 %)
31 diff
(97.8 %id)
BI770263 pooled lung and spleen .b 8085 to 8809 1 to 722       722/859
(84 %)
14 diff
(98.4 %id)
TI_57180108   .b 8085 to 8809 30 to 751       722/888
(81 %)
14 diff
(98.5 %id)
BU838455 dorsal root ganglia .b 8097 to 8958 32 to 897       866/993
(87 %)
16 diff
(98.4 %id)
DA794582 brain .b 8104 to 8641 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BP389252 pancreatic islet .b 8117 to 8556 440 to 1       440/440
(100 %)
0 diff
(100 %id)
BU621700 cell lines, Chondrosarcoma .b 8151 to 8877 738 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 720/720
(100 %)
7 diff
(99.1 %id)
R17822 whole brain .b 8212 to 8677 1 to 474       474/474
(100 %)
11 diff
(97.7 %id)
BP345774 synovial membrane .b 8223 to 8803 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP346455 synovial membrane .b 8223 to 8748 1 to 528       528/555
(95 %)
14 diff
(97.5 %id)
EH317499   .b 8224 to 8286 1 to 64       64/64
(100 %)
1 diff
(98.5 %id)
DA583739 lung .b 8227 to 8768 2 to 543   capped   542/543
(99 %)
1 diff
(99.9 %id)
DA006778   .b 8239 to 8817 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BE256624 eye, retinoblastoma .b 8297 to 8822 1 to 524       524/524
(100 %)
14 diff
(97.4 %id)
BE255630 eye, retinoblastoma .b 8297 to 8977 1 to 676       676/724
(93 %)
30 diff
(95.9 %id)
BM546903 ovary (pool of 3) .b 8389 to 9244 1 to 859       859/1050
(81 %)
10 diff
(99.1 %id)
AW954623   .b 8526 to 9120 10 to 602       593/602
(98 %)
6 diff
(99.1 %id)
AA351290 brain .b 8527 to 8927 1 to 403       403/404
(99 %)
7 diff
(98.3 %id)
BP223540 colon mucosa .b 8531 to 8984 1 to 457       457/458
(99 %)
11 diff
(97.6 %id)
R13960 whole brain .b 8550 to 8830 1 to 284       284/285
(99 %)
5 diff
(98.3 %id)
AW842099 colon_normal .b 8561 to 9183 644 to 22       623/644
(96 %)
0 diff
(100 %id)
DR159265 human embryonic stem cells differentiated toan early endodermal cell type .b 8562 to 9256 1 to 695       695/695
(100 %)
0 diff
(100 %id)
AL601380   .b 8565 to 9321 1 to 758       758/759
(99 %)
2 diff
(99.8 %id)
DA138136 alzheimer cortex .b 8571 to 8856 2 to 287   capped   286/286
(100 %)
0 diff
(100 %id)
BE872876 adenocarcinoma, colon .b 8597 to 8958 1 to 349       349/395
(88 %)
14 diff
(96.5 %id)
BG111512 Bone, osteosarcoma, cell line .b 8700 to 9410 1 to 708       708/951
(74 %)
31 diff
(96.8 %id)
BP289147 lung .b 8717 to 9170 1 to 453       453/580
(78 %)
12 diff
(98.0 %id)
BF761400 colon_est .b 8778 to 9173 15 to 407       393/423
(92 %)
6 diff
(98.6 %id)
BF761402 colon_est .b 8800 to 9173 60 to 435       376/451
(83 %)
22 diff
(95.2 %id)
BG034995 adenocarcinoma, cell line, Liver .b 8838 to 9570 1 to 731       731/959
(76 %)
25 diff
(97.4 %id)
BF761422 colon_est .b 8847 to 9173 1 to 327       327/343
(95 %)
4 diff
(98.9 %id)
BY798680 eye .b 8897 to 9501 1 to 605       605/605
(100 %)
0 diff
(100 %id)
N20372 melanocyte .b 8920 to 9297 1 to 381       381/381
(100 %)
7 diff
(98.2 %id)
BP418036 small intestine .b 8934 to 9431 1 to 499     Submitted on the opposite strand 499/499
(100 %)
1 diff
(99.8 %id)
BM423902 amelanotic melanoma, cell line, skin .b 9165 to 10180 1 to 1027       1027/1037
(99 %)
36 diff
(96.6 %id)
CD516820 White Matter .b 9192 to 9999 28 to 845   AAA   818/852
(96 %)
12 diff
(98.6 %id)
CA390248 eye, RPE/choroid .b 9202 to 9671 1 to 471       471/471
(100 %)
2 diff
(99.6 %id)
BM701917 eye, optic nerve .b 9208 to 9660 5 to 457   fully sequenced, Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 453/457
(99 %)
5 diff
(99.0 %id)
CN288527 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 9237 to 9917 1 to 682       682/684
(99 %)
9 diff
(98.7 %id)
CN288519 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 9272 to 9540 1 to 269       269/269
(100 %)
0 diff
(100 %id)
BI159850 epithelioid carcinoma cell line, Pancreas .b 9305 to 9879 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
TI_159723451   .b 9312 to 10261 1017 to 77   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 941/1006
(93 %)
24 diff
(97.7 %id)
BI765066 pooled colon, kidney, stomach .b 9331 to 9971 1 to 648       648/649
(99 %)
17 diff
(97.4 %id)
TI_57152955   .b 9331 to 9971 42 to 689       648/690
(93 %)
17 diff
(97.6 %id)
BM696151 eye, human retina .b 9458 to 9862 1 to 405       405/405
(100 %)
0 diff
(100 %id)
BM801694 duodenal adenocarcinoma, cell line, small intestine .b 9486 to 10272 811 to 21     Submitted on the opposite strand 791/895
(88 %)
0 diff
(100 %id)
H96014 melanocyte .b 9494 to 9734 1 to 245       245/253
(96 %)
5 diff
(98.1 %id)
BI258058 cervical carcinoma cell line, cervix .b 9526 to 10233 1 to 716       716/722
(99 %)
29 diff
(96.0 %id)
CA748936 cell lines, Chondrosarcoma .b 9545 to 10257 730 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 712/712
(100 %)
4 diff
(99.5 %id)
TI_149281276   .b 9551 to 10257 787 to 81   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 707/707
(100 %)
2 diff
(99.8 %id)
BQ028795 Bone, Subchondral Bone .b 9556 to 10257 721 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 703/703
(100 %)
2 diff
(99.8 %id)
BU679576 lung, Primary Lung Epithelial Cells .b 9572 to 10257 704 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 686/686
(100 %)
2 diff
(99.8 %id)
CA424884 cell lines, Chondrosarcoma .b 9587 to 10257 689 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 671/671
(100 %)
4 diff
(99.5 %id)
BM671070 eye, optic nerve .b 9630 to 10257 645 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 627/627
(100 %)
1 diff
(99.9 %id)
N32260 melanocyte .b 9654 to 10257 605 to 1       605/610
(99 %)
7 diff
(98.9 %id)
CA436384 Bone, Subchondral Bone .b 9684 to 10270 605 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 587/587
(100 %)
0 diff
(100 %id)
BU624662 cell lines, Enchondroma .b 9684 to 10261 596 to 19   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 578/578
(100 %)
0 diff
(100 %id)
CB242738 Human Lung Epithelial cells, lung .b 9685 to 10261 593 to 17   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 577/577
(100 %)
0 diff
(100 %id)
CA406558 adipose .b 9692 to 10266 580 to 6     Submitted on the opposite strand 575/580
(99 %)
0 diff
(100 %id)
AI743854 pooled .b 9694 to 10258 570 to 5       566/570
(99 %)
0 diff
(100 %id)
BM893890 Islets of Langerhans, Pancreas .b 9738 to 10266 533 to 5       529/533
(99 %)
0 diff
(100 %id)
EC492798 Prostate .b 9766 to 9856 1 to 88       88/88
(100 %)
3 diff
(96.6 %id)
R43025 whole brain .b 9808 to 10258 460 to 9       452/461
(98 %)
0 diff
(100 %id)
AA701626 liver and spleen .b 9809 to 10258 451 to 1       451/451
(100 %)
2 diff
(99.6 %id)
AL121527 melanoma (MeWo cell line) .b 9812 to 10477 1 to 660       660/660
(100 %)
10 diff
(98.5 %id)
R40020 whole brain .b 9812 to 10259 478 to 8       471/490
(96 %)
0 diff
(100 %id)
AI589511 anaplastic oligodendroglioma, brain .b 9812 to 10258 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
BG705916 brain, hypothalamus .b 9817 to 10502 1 to 686       686/710
(96 %)
11 diff
(98.5 %id)
N25284 nose, olfactory epithelium .b 9819 to 10258 448 to 5       444/451
(98 %)
0 diff
(100 %id)
N26870 melanocyte .b 9835 to 10257 423 to 1       423/423
(100 %)
0 diff
(100 %id)
R84963 brain .b 9840 to 10189 355 to 1       355/363
(97 %)
11 diff
(97.0 %id)
BQ129166 Islets of Langerhans, Pancreas .b 9845 to 10266 426 to 5       422/426
(99 %)
0 diff
(100 %id)
AW103114 pooled .b 9848 to 10258 414 to 4       411/414
(99 %)
0 diff
(100 %id)
AA670387 whole brain .b 9850 to 10257 418 to 12   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 407/407
(100 %)
1 diff
(99.8 %id)
BX107339 whole brain .b 9859 to 10257 413 to 15   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 399/401
(99 %)
0 diff
(100 %id)
AA505612 breast .b 9864 to 10258 396 to 1       396/396
(100 %)
4 diff
(99.0 %id)
R52027 breast .b 9876 to 10257 391 to 1       391/393
(99 %)
11 diff
(97.3 %id)
AA878890 2 pooled tumors (clear cell type), Kidney .b 9886 to 10229 30 to 373     Submitted on the opposite strand 344/373
(92 %)
6 diff
(98.4 %id)
N71713 melanocyte .b 9904 to 10257 363 to 1       363/363
(100 %)
8 diff
(97.8 %id)
N67713.
matches multiple genes
melanocyte .b 9906 to 10257 360 to 1     also hits gene ZADH2 360/362
(99 %)
10 diff
(97.3 %id)
AA283823 germinal center B cell .b 9915 to 10257 343 to 1       343/343
(100 %)
0 diff
(100 %id)
BU861160 mixed (pool of 40 RNAs) .b 9925 to 10262 1 to 338       338/869
(38 %)
5 diff
(99.5 %id)
CD250724 Blood vessels - aorta, basilar and artery .b 9925 to 10267 1 to 344       344/818
(42 %)
6 diff
(99.3 %id)
H96015 melanocyte .b 9930 to 10230 302 to 1       302/302
(100 %)
1 diff
(99.7 %id)
BE890007 leiomyosarcoma, uterus .b 9978 to 10257 1 to 278   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 278/278
(100 %)
4 diff
(98.6 %id)
CK821012 Islets of Langerhans, Pancreas .b 9979 to 10496 1 to 518   tiling clone, AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
BE669704 carcinoid, lung .b 9991 to 10206 1 to 216     Submitted on the opposite strand 216/218
(99 %)
1 diff
(99.6 %id)
BI793089 Islets of Langerhans, Pancreas .b 9995 to 10430 1 to 436       436/436
(100 %)
0 diff
(100 %id)
AA351289 brain .b 10033 to 10259 227 to 1       227/227
(100 %)
0 diff
(100 %id)
H41494 brain .b 10039 to 10256 219 to 1       219/219
(100 %)
2 diff
(99.1 %id)
AI684393 pooled .b 10061 to 10496 452 to 17   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 436/436
(100 %)
4 diff
(99.1 %id)
AI565590 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 10070 to 10496 427 to 1       427/427
(100 %)
0 diff
(100 %id)
EC486230 Prostate .b 10140 to 10262 25 to 143       119/143
(83 %)
6 diff
(95.9 %id)
AI619868 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 10190 to 10258 69 to 1       69/69
(100 %)
0 diff
(100 %id)
EH345416   .b 10427 to 10496 1 to 68   AAA Possibly primed on the genome, locally A rich (28/31 A in genome downstream of last aligned base) 68/68
(100 %)
2 diff
(97.1 %id)
BM551872 melanotic melanoma, skin .c 1 to 878 12 to 901 A151G K156X D162E R164K R169K tiling clone,   890/1077
(82 %)
40 diff
(96.3 %id)
FF848359   .d 1 to 2499 1 to 2499   tiling clone,   2499/2500
(99 %)
2 diff
(100.0 %id)
BF902912 marrow .d 559 to 979 1 to 422       422/423
(99 %)
8 diff
(98.2 %id)
CV337573 marrow .d 559 to 885 1 to 327       327/330
(99 %)
13 diff
(96.1 %id)
BF902911 marrow .d 626 to 969 1 to 345       345/345
(100 %)
3 diff
(99.2 %id)
BF902038 marrow .d 737 to 1128 395 to 1     Submitted on the opposite strand 395/396
(99 %)
4 diff
(99.0 %id)
BF360325 marrow .d 1193 to 1484 9 to 308       300/308
(97 %)
10 diff
(96.8 %id)
BU182955 melanotic melanoma, skin .d 2034 to 2726 1 to 693 K127X V128G L130V D146G V151G ... tiling clone,   874/879
(99 %)
14 diff
(98.5 %id)
DQ656051   .e 1 to 490 1 to 490 N28S T30A R71G S80G K88R tiling clone,   490/490
(100 %)
8 diff
(98.4 %id)
TI_57178825   .f 1 to 786 26 to 806   tiling clone,   781/807
(96 %)
15 diff
(98.2 %id)
BI767019 pooled lung and spleen .f 3 to 786 1 to 779   tiling clone,   779/780
(99 %)
11 diff
(98.6 %id)
DB495069 hypothalamus .g-u 1 to 468 1 to 469   tiling clone,   469/469
(100 %)
1 diff
(99.8 %id)
BC062546 Spleen .g-u 183 to 2723 1 to 2542 S66F P67A V68C G69R A70G ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2542/2542
(100 %)
1 diff
(100.0 %id)
BF921989 nervous_tumor .g-u 1516 to 1885 6 to 374       369/374
(98 %)
6 diff
(98.4 %id)
BF922012 nervous_tumor .g-u 1933 to 2307 376 to 1     Submitted on the opposite strand 376/376
(100 %)
7 diff
(98.2 %id)
BP431593   .g-u 1943 to 2341 1 to 399       399/399
(100 %)
4 diff
(99.0 %id)
AF150381 umbilical cord blood .g-u 2058 to 2444 1 to 387       387/387
(100 %)
0 diff
(100 %id)
AV735686 cord Blood .g-u 2058 to 2445 36 to 413   AAA   378/413
(91 %)
6 diff
(98.6 %id)
BF923440 nervous_tumor .g-u 2140 to 2511 388 to 16     Submitted on the opposite strand 373/388
(96 %)
0 diff
(100 %id)
DB566113 hypothalamus .g-u 2253 to 2723 1 to 471     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
AW274470 pooled .g-u 2296 to 2727 432 to 1   tiling clone,   432/432
(100 %)
2 diff
(99.6 %id)
FF848354   .h 1 to 1198 1196 to 1 exact tiling clone, Submitted on the opposite strand 1196/1196
(100 %)
2 diff
(99.9 %id)
FF848345   .h 42 to 1174 1134 to 1   tiling clone, Submitted on the opposite strand 1132/1134
(99 %)
2 diff
(99.9 %id)
FF848349   .i 1 to 1088 1087 to 1 exact tiling clone, Submitted on the opposite strand 1087/1087
(100 %)
0 diff
(100 %id)
BF906394 ovary .i 45 to 382 29 to 371       343/371
(92 %)
6 diff
(98.4 %id)
FF848344   .i 100 to 1064 965 to 1   tiling clone, Submitted on the opposite strand 965/965
(100 %)
0 diff
(100 %id)
BP327788 prostata .j 1 to 550 1 to 549   tiling clone,   549/582
(94 %)
16 diff
(97.3 %id)
BE564145 bone marrow, from chronic myelogenous leukemia .j 304 to 775 1 to 467 C11V A12L L13V Q15E K16I ... tiling clone,   467/636
(73 %)
10 diff
(98.5 %id)
AW811762 stomach .j 312 to 545 1 to 234   tiling clone,   234/234
(100 %)
3 diff
(98.8 %id)
CV359039 colon_normal .k 1 to 256 1 to 255   tiling clone,   255/255
(100 %)
11 diff
(95.7 %id)
FF848343   .k 249 to 659 411 to 1     Submitted on the opposite strand 411/411
(100 %)
1 diff
(99.8 %id)
FF848351   .k 249 to 684 435 to 1   tiling clone, Submitted on the opposite strand 435/435
(100 %)
1 diff
(99.8 %id)
FF848353   .k 249 to 684 437 to 2   tiling clone, Submitted on the opposite strand 436/438
(99 %)
2 diff
(99.6 %id)
AI475760 B-cell, chronic lymphotic leukemia .l-u 1 to 442 442 to 1 exact tiling clone,   442/442
(100 %)
0 diff
(100 %id)
DQ656049   .m 1 to 342 1 to 342 exact tiling clone,   342/342
(100 %)
0 diff
(100 %id)
FF848347   .m 39 to 341 302 to 1     Submitted on the opposite strand 302/302
(100 %)
0 diff
(100 %id)
BF811548 colon_ins .n-u 1 to 269 1 to 268 T14A V24X tiling clone,   268/276
(97 %)
3 diff
(99.0 %id)
AB209464 brain Gene MECP2, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
FF848340   Gene MECP2, variant not shown         Submitted on the opposite strand    
FF848341   Gene MECP2, variant not shown         Submitted on the opposite strand    
FF848346   Gene MECP2, variant not shown         Submitted on the opposite strand    
FF848355   Gene MECP2, variant not shown         Submitted on the opposite strand    
FF848357   Gene MECP2, variant not shown         Submitted on the opposite strand    
H99226 melanocyte Gene MECP2, variant not shown         Suspected internal deletion, this clone was ignored    
N26343 melanocyte Gene MECP2, variant not shown         Suspected internal deletion, this clone was ignored    
AI742297 pooled Gene MECP2, variant not shown         Suspected internal deletion, this clone was ignored    
BM986904 mixed Gene MECP2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BE733400 choriocarcinoma, placenta Gene MECP2, variant not shown         Suspected internal deletion, this clone was ignored    
BE733026 choriocarcinoma, placenta Gene MECP2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j, .k, .l-u, .m, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI